Literature DB >> 10394556

Uterine rupture after use of a prostaglandin E2 vaginal insert during vaginal birth after cesarean. A report of two cases.

K S Raskin1, J D Dachauer, A L Doeden, W F Rayburn.   

Abstract

BACKGROUND: Prostaglandin E2, when used for cervical ripening, often initiates labor. Single dosing and ease of removal contribute to the common use of a commercially available prostaglandin E2 vaginal insert. We describe two cases of uterine rupture among 57 pregnancies undergoing attempted vaginal birth after cesarean section. CASES: Two cases of women attempting vaginal birth after a single low transverse cesarean section were treated with the insert either at 41 weeks, 4 days, or 39 weeks, 3 days, for postdatism or preeclampsia. Signs of uterine rupture included persistent suprapubic pain and repetitive fetal heart rate variable decelerations followed by bradycardia. Infant outcomes were favorable, and tears along the prior low transverse uterine scar were repaired without additional morbidity.
CONCLUSION: This prostaglandin compound is not exempt from being associated directly or indirectly with uterine rupture and requires informed consent and continuous monitoring.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394556

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  1 in total

1.  Induction of labor with prostaglandin e2 in women with previous cesarean section and unfavorable cervix.

Authors:  Abdul-Kareem Alsayegh; Salah Roshdy; A Hany Akef; S Maha Youssef
Journal:  Int J Health Sci (Qassim)       Date:  2007-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.